Role of Aberrant Spontaneous Neurotransmission in SNAP25-Associated Encephalopathies.
Alten, B., Zhou, Q., Shin, O.H., Esquivies, L., Lin, P.Y., White, K.I., Sun, R., Chung, W.K., Monteggia, L.M., Brunger, A.T., Kavalali, E.T.(2021) Neuron 109: 59-72.e5
- PubMed: 33147442 
- DOI: https://doi.org/10.1016/j.neuron.2020.10.012
- Primary Citation of Related Structures:  
6WVW - PubMed Abstract: 
SNARE (soluble N-ethylmaleimide sensitive factor attachment protein receptor) complex, composed of synaptobrevin, syntaxin, and SNAP25, forms the essential fusion machinery for neurotransmitter release. Recent studies have reported several mutations in the gene encoding SNAP25 as a causative factor for developmental and epileptic encephalopathies of infancy and childhood with diverse clinical manifestations. However, it remains unclear how SNAP25 mutations give rise to these disorders. Here, we show that although structurally clustered mutations in SNAP25 give rise to related synaptic transmission phenotypes, specific alterations in spontaneous neurotransmitter release are a key factor to account for disease heterogeneity. Importantly, we identified a single mutation that augments spontaneous release without altering evoked release, suggesting that aberrant spontaneous release is sufficient to cause disease in humans.
Organizational Affiliation: 
Department of Pharmacology, Vanderbilt University, Nashville, TN 37240-7933, USA; Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 37240-7933, USA.